health_en

Novavax Announces Positive Results of COVID-19 Vaccine in Pediatric Population of PREVENT-19 Phase 3 Clinical Trial

– PREVENT-19 pediatric expansion in adolescents aged 12 through 17 achieved primary effectiveness endpoint demonstrating comparability to adult population – Trial demonstrated 82% clinical efficacy against Delta variant – Immune responses were about two-to-three-fold higher in adolescents than in adults against all variants studied – Vaccine was well-tolerated with no safety signals identified – Novavax plans to…

thaipr.net

11 ก.พ. 65

X-Chem and Excelra’s GOSTAR Join Forces to Advance Drug Discovery for Challenging Targets

A new collaboration between data science and analytics leader, Excelra, and artificial intelligence pioneer X-Chem will accelerate preclinical drug discovery and aid scientists to find new drug candidates for currently hard-to-drug targets. Machine learning and artificial intelligence are reshaping discovery and optimization of drug candidates. This synergistic new partnership between Excelra’s GOSTAR and X-Chem’s RosalindAI…

thaipr.net

11 ก.พ. 65

Well Begun AND Half Done! – SIRONA Randomized Trial Achieves fifty percent enrollment

Concept Medical Inc., focused on vascular intervention drug delivery devices, releases the second status update of SIRONA RCT (Head-to-Head Comparison of SIROlimus versus Paclitaxel Drug-Eluting BallooNAngioplasty in the Femoropopliteal Artery), as the trial completes half the targeted enrolment. SIRONA is the world’s first and the largest head-to-head RCT investigating the use of Sirolimus DCB (Magic Touch PTA – Concept […]

thaipr.net

11 ก.พ. 65

Glenmark and SaNOtize announce positive Results from Phase 3 Clinical Trial of NONS (FabiSpray®) in Non-Hospitalized Adult Indian Patients with COVID-19

Phase 3 trial in India met the key endpoints and demonstrated reduction of viral load of 94% in 24 hours and 99% in 48 hours. NONS was safe and well tolerated in COVID-19 patients. Glenmark received manufacturing and marketing approval from India’s drug regulator for Nitric Oxide Nasal Spray (NONS) as part of accelerated approval […]

thaipr.net

10 ก.พ. 65

Cambrex Recognized with 2022 CMO Leadership Awards for the 8th Consecutive Year

Cambrex, a leading global contract development and manufacturing organization (CDMO), announced today that it has been recognized by the annual CMO (Contract Manufacturing Organization) Leadership Awards in the categories of Quality and Service. This marks the eighth consecutive year Cambrex has been acknowledged with an award. “Cambrex is honored to be identified once again by […]

thaipr.net

9 ก.พ. 65

The one-component Sputnik Light vaccine has been authorized in India; over 2.5 billion people live in countries that approved Sputnik Light as a standalone vaccine and a universal booster

Sputnik Light will be an important part of India’s vaccination program and the fight against mutations of COVID, including Omicron. Sputnik Light has been authorized in more than 30 countries with total population of over 2.5 billion people. The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund) announces the Russian one-shot Sputnik Light vaccine […]

thaipr.net

7 ก.พ. 65

Medicines and Healthcare Products Regulatory Agency Grants Conditional Marketing Authorization for Novavax COVID-19 Vaccine in Great Britain*

Nuvaxovid™ COVID-19 Vaccine (recombinant, adjuvanted)▼ is the first protein-based COVID-19 vaccine authorized in Great Britain Novavax and the U.K. Vaccines Taskforce previously announced an agreement for up to 60 million doses Authorization based on data including an ongoing pivotal Phase 3 trial conducted in the U.K. with almost 15,000 participants Novavax, Inc. (Nasdaq: NVAX), a […]

thaipr.net

4 ก.พ. 65
1 … 80 81 82 83 84 … 128

Copyright © 2025 Dataxet Limited (บริษัท ดาต้าเซ็ต จำกัด). All Rights Reserved.